Cellares logo

Cellares

Accelerating Access to Life-Saving Cell Therapies

322 employees · est. 2019 · South San Francisco, United...

VS
WuXi Advanced Therapies logo

WuXi Advanced Therapies

An integrated cell and gene therapy Contract Testing, Development and Manufacturing Organization (CTDMO)

412 employees · est. 2004 · Philadelphia, United States

WuXi Advanced Therapies is the older company (2019 vs 2004).

Side-by-Side Comparison

Cellares WuXi Advanced Therapies
Founded
2019 2004 older
Headquarters
South San Francisco, United States Philadelphia, United States
Employees
322 412
Industry
Biotechnology, Pharmaceutical Biotechnology, Life Sciences, Manufacturing
Funding Stage
Series D Not tracked yet
Total Funding
$612.00M Not tracked yet
Funding Rounds
4 Not tracked yet
Services
Cell Shuttle® Platform, Cell Q™ Platform, Clinical & Commercial Manufacturing, Analytical Method Automation, Process Automation, Quality and Regulatory Consultation Not tracked yet
Target Customers
Biopharmaceutical Companies, Cell Therapy Developers, Pharmaceutical Companies Not tracked yet
Taxonomy
Integrated Development And Manufacturing Organization, Cell Therapy, Industry 4.0, Automated Manufacturing, Cell Shuttle, Cell Q, Smart Factories, Advanced Manufacturing Technology, FDA Compliance, Oncology, Autoimmune Indications, Clinical Manufacturing, Process Automation, Scalable Manufacturing, Cost Reduction Cell Therapy, Gene Therapy, Process Development, Virology, CAR-T, CDMO, CMO, Biomanufacturing, Bioprocessing, Protein Therapeutic, Immunotherapy, Laboratory Testing, Analytical Development, Vaccine Manufacturing
Website
cellares.com advancedtherapies.com
Cellares logo

About Cellares

Cellares, founded in 2019 and headquartered in the United States, is at the forefront of revolutionizing cell therapy manufacturing. As the first Integrated Development and Manufacturing Organization (IDMO), Cellares delivers on its promise of "Accelerating Access to Life-Saving Cell Therapies" by d...

WuXi Advanced Therapies logo

About WuXi Advanced Therapies

WuXi Advanced Therapies is the leading integrated cell and gene therapy Contract Testing, Development, and Manufacturing Organization (CTDMO). Founded in 2004 and headquartered in the United States, their slogan "Accelerating Progress and Time to Market" reflects their core mission. The company offe...

We will tell you when either one moves

BounceWatch watches Cellares and WuXi Advanced Therapies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cellares and WuXi Advanced Therapie... — by email.

Frequently Asked Questions

Cellares — Accelerating Access to Life-Saving Cell Therapies. WuXi Advanced Therapies — An integrated cell and gene therapy Contract Testing, Development and Manufacturing Organization (CTDMO). Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cellares has raised $612.00M while WuXi Advanced Therapies has raised undisclosed funding.
Cellares and WuXi Advanced Therapies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cellares with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cellares on 15 Jun 2026, and WuXi Advanced Therapies on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes